Grant Howes,
Vice President, Commercial Operations ,
Celsee Diagnostics
Throughout his career, Grant Howes, VP, Commercial Operations, Celsee Diagnostics, has focused on the medical diagnostic and life science research cell analyses marketplaces. Prior to joining Celsee Diagnostics, Grant was Director of Marketing at BD Biosciences, where he had global responsibilities for personal cell-analysis systems in addition to the HIV/AIDS Initiative. Prior to that, he was VP of Marketing at Accuri Cytometers, Inc. and Director of Marketing at Beckman Coulter, Inc. Before relocating to the United States in 1998, Grant held marketing and technical positions at Coulter Electronics in the UK.
Automated, Sensitive Microfluidic Device for CTC Capturing and Characterization
Friday, 30 September 2016 at 13:30
Add to Calendar ▼2016-09-30 13:30:002016-09-30 14:30:00Europe/LondonAutomated, Sensitive Microfluidic Device for CTC Capturing and CharacterizationLiquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
The Celsee Diagnostics’ novel microfluidic technology captures and characterizes CTCs from metastatic cancer patients’ whole blood samples based on size and deformability. The design enables downstream characterization of CTCs, including IHC, FISH, PCR and NGS.
This presentation will overview the technology, demonstrate the 85% capture efficiency and discuss the use of the Celsee PREP100 to enrich and retrieve CTCs for downstream applications. The Celsee PREP100 device uses a microfluidic chip, which has approximately 56,400 individual cell capturing wells. Each well ensures that smaller blood cells, such as red blood cells and most leukocytes, escape while larger CTCs are captured.
Downstream analysis of the captured CTCs using immuno-staining, FISH assays, RTPCR and NGS will be highlighted.
Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2016Liquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2016-09-30 13:30:002016-09-30 14:30:00Europe/LondonAutomated, Sensitive Microfluidic Device for CTC Capturing and CharacterizationLiquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
